MarketCap
Facebook
X
Telegram
Aclaris Therapeutics ROE Ratio | ACRS
Annual ROE Ratio Aclaris Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.98 | -84.9 | -56.29 | -43.98 | -46.04 | -135.5 | -230.8 | -61.7 | -30.42 | -28.37 | -22.23 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -22.23 | -230.8 | -73.02 |
Quarterly ROE Ratio Aclaris Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61.36 | -62.43 | -56.88 | -53.55 | -96.42 | -90.08 | -86.58 | -88.04 | -26.92 | -39.8 | -48.04 | -52.04 | -65.08 | -55.44 | -47.7 | -42.2 | -39.77 | -40.46 | -39.51 | -54.69 | -78.12 | -94.51 | -110.24 | -111.44 | -103.04 | -141.76 | -154.62 | -148.42 | -139.75 | -97.25 | -78.83 | -73.29 | -65.55 | -50.63 | -39.29 | -29.79 | -26.38 | -25.24 | -26.25 | -28.37 | -26.92 | -32.1 | -27.31 | -22.46 | -4.62 | 19.68 | -2.84 | 12.51 | 12.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.68 | -154.62 | -57.98 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
NeuroBo Pharmaceuticals
NRBO
|
-243.26 | - | 0.43 % | $ 12 M |  USA |
 |
OncoCyte Corporation
OCX
|
0.16 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
-1457.87 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
80.96 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-366.23 | $ 8.55 | -8.85 % | $ 593 M | USA |
 |
BiomX
PHGE
|
2780.26 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-149.07 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-560.21 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
103.41 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-60.7 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-5.1 | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
-122.27 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
103.22 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
861.59 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-212.58 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-113.41 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-148.43 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-154.32 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-8.47 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-45.74 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-199.0 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
5.5 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
37.78 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-56.04 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
216.69 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-17.88 | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
-20.94 | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-139.05 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-170.94 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-125.3 | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
269.84 | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-185.29 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-22.91 | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
-152.74 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
88.41 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-33.23 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-68.38 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-97.66 | $ 4.21 | 4.99 % | $ 653 M | USA |
 |
AbbVie
ABBV
|
-55.54 | $ 291.22 | 1.06 % | $ 515 B | USA |
 |
22nd Century Group
XXII
|
-32.07 | $ 1.56 | -19.17 % | $ 287 K | USA |
 |
Axon Enterprise
AXON
|
3.84 | $ 313.68 | -18.01 % | $ 24.5 B | USA |
 |
Biogen
BIIB
|
7.08 | $ 248.51 | 1.88 % | $ 36.4 B | USA |
 |
BioLineRx Ltd.
BLRX
|
-8.68 | $ 1.73 | -2.15 % | $ 4.26 B | Israel |
 |
Theratechnologies
THTX
|
32.87 | - | - | $ 83.9 M | Canada |
 |
Exelixis
EXEL
|
36.21 | $ 69.55 | 1.22 % | $ 18.9 B | USA |